prazosin has been researched along with Deficiency, Vitamin E in 1 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamitani, T | 1 |
| Katsuta, K | 1 |
| Sakai, S | 1 |
| Sakata, Y | 1 |
| Motoyama, Y | 1 |
| Horiai, H | 1 |
| Ono, T | 1 |
| Kikuchi, H | 1 |
| Kumada, S | 1 |
1 other study available for prazosin and Deficiency, Vitamin E
| Article | Year |
|---|---|
Protective effect of FR35447 on experimental cerebral infarction.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcimycin; Cardiovascular Agents; Cerebral Infarction | 1984 |